Forward to a friend |
Subscribe | The Record Archive | Contacts | bcbsm.com | Print this article
|
October 2022
Starting Dec. 1, new prior authorizations are required for opioid medications exceeding 90 MMEsBlue Cross Blue Shield of Michigan and Blue Care Network remain committed to battling our country’s opioid crisis through various programs and initiatives. Starting Dec. 1, 2022, health care providers must submit a new prior authorization to extend prescriptions for members who are taking opioids with a dosage exceeding 90 morphine milligram equivalents, or MMEs, if these members don’t have a current prior authorization in place. Providers use MMEs to measure and compare different drugs, using morphine as the standard. Blue Cross requires a prior authorization for opioid dosages that exceed 90 MMEs per day. Prescription opioids are powerful pain-reducing medications. Examples include prescription medications containing oxycodone, hydrocodone or codeine, and may go by the brand names of Vicodin®, Norco® and Tylenol® No. 3, among others. We’ll notify affected members and recommend they reach out to their providers. |
|
No portion of this publication may be copied without the express written permission of Blue Cross Blue Shield of Michigan, except that BCBSM participating health care providers may make copies for their personal use. In no event may any portion of this publication be copied or reprinted and used for commercial purposes by any party other than BCBSM.
|